The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,738,639 in first-year total cost, median $534,072.
Most frequent study sections
- Behavioral and Social Consequences of HIV/AIDS Study Section[BSCH]1
- Somatosensory and Chemosensory Systems Study Section[SCS]1
- Special Emphasis Panel[ZRG1 AARR-N (02)]1
- Special Emphasis Panel[ZRG1 BBBP-T (03)]1
- Synthetic and Biological Chemistry B Study Section[SBCB]1
Most frequent institutions
- ALBERT EINSTEIN COLLEGE OF MEDICINE, INC1
- SCRIPPS RESEARCH INSTITUTE, THE1
- UNIVERSITY OF ARIZONA1
- UNIVERSITY OF CALIFORNIA, SAN DIEGO1
- VIRGINIA COMMONWEALTH UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | Does medical cannabis reduce opioid analgesics in HIV+ and HIV- adults with pain?1R01DA044171-01A1 | CUNNINGHAM, CHINAZO | ALBERT EINSTEIN COLLEGE OF MEDICINE, INC, NY | $802,762 | ZRG1 |
| 2017 | Effect of Cannabis Administration and Endocannabinoids on HIV Neuropathic Pain1R01DA043430-01 | ELLIS, RONALD J.HENRY, BROOK | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $618,199 | BSCH |
| 2017 | Endocannabinoid modulation of pain-depressed behavior2R01DA030404-06A1 | NEGUS, SIDNEY SSIM-SELLEY, LAURA J | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $534,072 | ZRG1 |
| 2017 | Modulating Signaling Endocannabinoids and Fatty Acid Amides2R01DA015648-11 | BOGER, DALE L | SCRIPPS RESEARCH INSTITUTE, THE, CA | $433,125 | SBCB |
| 2017 | Cannabinoid CB2 Agonists for Treatment of Breast Cancer Induced Bone Pain2R01CA142115-06A1 | VANDERAH, TODD W | UNIVERSITY OF ARIZONA, AZ | $350,481 | SCS |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.